Candela produces hydrofoiling electric boats and ferries. The company focuses on creating silent, fast, and zero-emission vessels using innovative hydrofoil technology to improve energy efficiency.

Candela

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

RVL Pharmaceuticals plc

h.team provides automation solutions. The company offers a range of products and services including managed and unmanaged switches, routers, industrial firewall systems, I/O components, and security controls.

Metric
Company Name	Candela	RVL Pharmaceuticals plc	h.team
Symbol		RVLP
MSH ID	COM:CANDELA	COM:RVLPHARMA	DE:H-TEAM
Market	PRIVATE	STOCKS	PRIVATE
Sector	Transportation	Healthcare	Technology
Industry	Marine and Water Transportation	Biotechnology	Electronics & Electrical Equipment
Country	SE	US	DE
Stage	Series C
Employee Count		125
Website	candela.com	rvlpharma.com	h-team.de
LinkedIn
Founders

Metric
Market Cap		3.14M
Enterprise Value
Monthly Web Traffic	37.64K
Web Traffic Growth	-0.52
Valuation
Raised Capital	14M

Metric
Revenue		49.72M
Revenue (LTM)
Revenue (NTM)
Gross Profit		40.27M
EBITDA		-36.19M
Operating Income		-45.68M
Net Income		-51.69M
EPS		-0.58
Diluted EPS		-0.58
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.75
Operating Profit Margin		-1.56
EBITDA Margin		-0.73
Net Profit Margin		-1.85
Return on Equity		-1.55
Return on Assets		-0.80
Return on Capital Employed		-3.38

COM:CANDELA

Candela

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.04
P/B Ratio		0.17
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.09
EV Multiple		0.99

Metric
Days Sales Outstanding		19.10
Days Payables Outstanding		98.98
Days Inventory Outstanding		53.05
Operating Cycle		72.15
Cash Conversion Cycle		-26.83
Asset Turnover		0.43

Metric
Operating Cash Flow		-37.81M
Free Cash Flow		-38.56M
Cash Flow to Debt		-0.76
Operating Cash Flow/Sales		-1.20
Free Cash Flow Yield		-15.11

Metric
Cash & Equivalents		44.54M
Accounts Receivable		-898K
Inventory		784K
Goodwill		55.85M
Debt to Capitalization		0.78
Debt to Assets		0.68
Current Ratio		0.38
Quick Ratio		0.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.06
R&D to Revenue		0.08
SG&A to Revenue